US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM on Dec. 16 for "Prediction and treatment of immunotherapeutic toxicity" (Texas Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,381, issued on Dec. 16, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Prediction and treatment of immunotherapeutic toxicity" was invented by David E. Gerber (Dallas), Edward Wakeland (Dallas), Quan-Zhen Li (Dallas), Saad Khan (Dallas), Jason Y. Park (Dallas), Xin Luo (Dallas) and Yang Xie (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies."

The patent was filed on June 21, 2023, under Applicatio...